MOLGENIS VIP: an end-to-end DNA variant interpretation pipeline for research and diagnostics configurable to support rapid implementation of new methods.
Willem T K Maassen, Lennart F Johansson, Bart Charbon, Dennis Hendriksen, Sander van den Hoek, Mariska K Slofstra, Renée Mulder, Martine T Meems-Veldhuis, Robert Sietsma, Henny H Lemmink, Cleo C van Diemen, Mariëlle E van Gijn, Morris A Swertz, Kasper J van der Velde
{"title":"MOLGENIS VIP: an end-to-end DNA variant interpretation pipeline for research and diagnostics configurable to support rapid implementation of new methods.","authors":"Willem T K Maassen, Lennart F Johansson, Bart Charbon, Dennis Hendriksen, Sander van den Hoek, Mariska K Slofstra, Renée Mulder, Martine T Meems-Veldhuis, Robert Sietsma, Henny H Lemmink, Cleo C van Diemen, Mariëlle E van Gijn, Morris A Swertz, Kasper J van der Velde","doi":"10.1093/nargab/lqaf087","DOIUrl":null,"url":null,"abstract":"<p><p>Achieving high yield in genetics research and genome diagnostics is a significant challenge because it requires a combination of multiple strategies and large-scale genomic analysis using the latest methods. Existing diagnostic software infrastructures are often unable to cope with high demands for versatility and scalability. We developed MOLGENIS VIP, a flexible, scalable, high-throughput, open-source, and \"end-to-end\" pipeline to process different types of sequencing data into portable, prioritized variant lists for immediate clinical interpretation in a wide variety of scenarios. VIP supports interpretation of short- and long-read sequencing data, using best-practice annotations and classification trees without complex IT infrastructures. VIP is developed within the long-living MOLGENIS open-source project to provide sustainability and has integrated feedback from a growing international community of users. VIP has undergone genome diagnostic laboratory testing and harnesses experiences from multiple Dutch, European, Canadian, and African diagnostic and infrastructural initiatives (VKGL, EU-Solve-RD, EJP-RD, CINECA, GA4GH). We provide a step-by-step protocol for installing and using VIP. We demonstrate VIP using 25 664 previously classified variants from the VKGL, and 18 and 41 diagnosed patients from a routine diagnostics and a Solve-RD research cohort, respectively. We believe that VIP accelerates causal variant detection and innovation in genome diagnostics and research.</p>","PeriodicalId":33994,"journal":{"name":"NAR Genomics and Bioinformatics","volume":"7 2","pages":"lqaf087"},"PeriodicalIF":2.8000,"publicationDate":"2025-06-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12205968/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"NAR Genomics and Bioinformatics","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1093/nargab/lqaf087","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/6/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"GENETICS & HEREDITY","Score":null,"Total":0}
引用次数: 0
Abstract
Achieving high yield in genetics research and genome diagnostics is a significant challenge because it requires a combination of multiple strategies and large-scale genomic analysis using the latest methods. Existing diagnostic software infrastructures are often unable to cope with high demands for versatility and scalability. We developed MOLGENIS VIP, a flexible, scalable, high-throughput, open-source, and "end-to-end" pipeline to process different types of sequencing data into portable, prioritized variant lists for immediate clinical interpretation in a wide variety of scenarios. VIP supports interpretation of short- and long-read sequencing data, using best-practice annotations and classification trees without complex IT infrastructures. VIP is developed within the long-living MOLGENIS open-source project to provide sustainability and has integrated feedback from a growing international community of users. VIP has undergone genome diagnostic laboratory testing and harnesses experiences from multiple Dutch, European, Canadian, and African diagnostic and infrastructural initiatives (VKGL, EU-Solve-RD, EJP-RD, CINECA, GA4GH). We provide a step-by-step protocol for installing and using VIP. We demonstrate VIP using 25 664 previously classified variants from the VKGL, and 18 and 41 diagnosed patients from a routine diagnostics and a Solve-RD research cohort, respectively. We believe that VIP accelerates causal variant detection and innovation in genome diagnostics and research.